Opinion|Videos|June 11, 2024
Balancing Clinical and Economic Factors in Early Breast Cancer Treatment
The panelists discuss the clinical and economic factors that influence treatment decisions for early breast cancer (eBC), as well as the differences between eBC and metastatic breast cancer (mBC) in terms of adverse event management protocols and strategies for optimizing patient adherence.
Advertisement
Episodes in this series
Video content above is prompted by the following questions:
- What is the current standard of care for early breast cancer?
- What role do academic and community pharmacists have in the treatment plan?
- What are the clinical and economic considerations that go into deciding on a treatment option for eBC?
- What is the difference between eBC and mBC in terms of AE protocols and adherence optimization?
- Can any mBC practices apply to eBC?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Semaglutide Reduces Time in Spent in Hospital, Admission Rates in Patients With Overweight or Obesity
2
From the Pharmacy Counter to the Kitchen Cabinet: Helping Patients Choose Quality Supplements
3
Atebimetinib Signals a Potential Shift in First-Line Pancreatic Cancer Outcomes
4
What Pharmacists Should Know About Most Favored Nation as Drug Prices Continue to Rise
5